Mortality-Reducing Effect of Rehabilitation for COPD: Observational Propensity-Matched Cohort Study Using a Nationwide Database

Abstract

BACKGROUND:

In the course of therapy of patients with COPD, non-pharmacologic treatment, such as rehabilitation, plays an important role. Although some studies have provided concrete evidence of the effectiveness of rehabilitation in improving functional outcomes in subjects with COPD, evidence of its mortality-reducing effect has been insufficient. In the present study, we examined whether rehabilitation had positive effects on in-hospital mortality of subjects with COPD.

METHODS:

We used the Japanese Diagnosis Procedure Combination nationwide administrative claims database. This was a retrospective cohort study, and there were 18,037 eligible subjects with COPD from 1,055 hospitals. The main outcome was in-hospital mortality rates. A one-to-one propensity score matching method was used to compare hospital mortality rates after admission between rehabilitation and non-rehabilitation groups.

RESULTS:

A total of 3,356 pairs of subjects were selected from the rehabilitation and non-rehabilitation groups (n = 6,712). Subjects in the rehabilitation program showed a reduction in the odds of mortality (odds ratio = 0.80, 95% CI 0.65–1.00, P = .045). In the subgroup analyses, the rehabilitation group had a lower in-hospital mortality in the pre-obese subgroup (body mass index 25.0–29.9) than the non-rehabilitation group (P = .02). Although not significant, the rehabilitation group showed a relatively low in-hospital mortality in the Hugh-Jones dyspnea scale class 5 subgroup (P = .066).

CONCLUSIONS:

This large nationwide cohort study showed that rehabilitation indeed contributed to a reduction of in-hospital mortality. These findings underscore the importance of adopting rehabilitation as part of the treatment of COPD.

Keywords

COPD rehabilitation mortality propensity score retrospective cohort study diagnosis procedure combination

Get full access to this article

View all access options for this article.

References

Celli

, MacNee

. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J, 2004; 23(6):932–946.

Hay

, Stone

, Carter

, Church

, Eyre-Brook

, Pearson

, et al. Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease. Eur Respir J, 1992; 5(6):659–664.

World Health Organization. World Health Report 2000. http://www.who.int/whr/2000/en/. Accessed April 18, 2016.

Mathers

, Loncar

. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med, 2006; 3(11):e442.

Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2015. http://www.goldcopd.org/uploads/users/files/GOLD_Report_2015_Feb18.pdf.

European Respiratory Society. European Lung White Book: European Respiratory Society Journals. http://www.erswhitebook.org/.

National Heart, Lung, and Blood Institute. Morbidity & Mortality 2012 Chart Book on Cardiovascular, Lung and Blood Diseases. US Department of Health and Human Services, Public Health Service, National Institutes of Health. 2012. http://www.nhlbi.nih.gov/files/docs/research/2012_ChartBook.pdf.

Nici

, Donner

, Wouters

, Zuwallack

, Ambrosino

, Bourbeau

, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med, 2006; 173(12):1390–1413.

British Thoracic Society Standards of Care Subcommittee on Pulmonary Rehabilitation. Pulmonary rehabilitation. Thorax, 2001; 56(11):827–834.

10.

Ries

, Bauldoff

, Carlin

, Casaburi

, Emery

, Mahler

, et al. Pulmonary rehabilitation: Joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest, 2007; 131(5):4S–42S.

11.

Puhan

, Gimeno-Santos

, Scharplatz

, Troosters

, Walters

, Steurer

. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 2011;(10):CD005305.

12.

Behnke

, Jörres

, Kirsten

, Magnussen

. Clinical benefits of a combined hospital and home-based exercise programme over 18 months in patients with severe COPD. Monaldi Arch Chest Dis, 2003; 59(1):44–51.

13.

Man

, Polkey

, Donaldson

, Gray

, Moxham

. Community pulmonary rehabilitation after hospitalization for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study. BMJ, 2004; 329(7476):1209.

14.

Troosters

, Gosselink

, Decramer

. Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Am J Med, 2000; 109(3):207–212.

15.

Matsuda

, Ishikawa

, Kuwabara

, Fujimori

, Fushimi

, Hashimoto

. Development and use of the Japanese case-mix system. Eurohealth, 2008; 14:25–30.

16.

Shoda

, Yasunaga

, Horiguchi

, Matsuda

, Ohe

, Kadono

, Tanaka

. Risk factors affecting inhospital mortality after hip fracture: retrospective analysis using the Japanese Diagnosis Procedure Combination database. BMJ Open, 2012; 2(3):e000416. doi: 10.1136/bmjopen-2011-000416.

17.

Chikuda

, Yasunaga

, Horiguchi

, Takeshita

, Kawaguchi

, Matsuda

, Nakamura

. Mortality and morbidity in dialysis-dependent patients undergoing spinal surgery: analysis of a national administrative database in Japan. J Bone Joint Surg Am, 2012; 94(5):433–438.

18.

WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet, 2004; 363(9403):157–163.

19.

Quan

, Sundararajan

, Halfon

, Fong

, Burnand

, Luthi

, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care, 2005; 43(11):1130–1139.

20.

Rosenbaum

, Rubin

. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat, 1985; 39:33–38.

21.

Yasunaga

, Horiguchi

, Kuwabara

, Matsuda

, Fushimi

, Hashimoto

, Ayanian

. Outcomes after laparoscopic or open distal gastrectomy for early-stage gastric cancer: a propensity-matched analysis. Ann Surg, 2013; 257(4):640–646.

22.

Ayanian

, Landrum

, Guadagnoli

, Gaccione

. Specialty of ambulatory care physicians and mortality among elderly patients after myocardial infarction. N Engl J Med, 2002; 347(21):1678–1686.

23.

Tashkin

, Celli

, Senn

, Burkhart

, Kesten

, Menjoge

, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med, 2008; 359(15):1543–1554.

24.

European Respiratory Society. An International Comparison of COPD Care in Europe Results of the First European COPD Audit. 2012. http://www.ersnet.org/images/copd_audit_web_version.pdf. Accessed April 18, 2016.

25.

Mannino

, Homa

, Akinbami

, Ford

, Redd

. Chronic obstructive pulmonary disease surveillance: United States, 1971-2000. MMWR Surveill Summ, 2002; 51(6):1–16.

26.

Schols

, Slangen

, Volovics

, Wouters

. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 1998; 157(6 Pt 1):1791–1797.

27.

Lainscak

, von Haehling

, Doehner

, Sarc

, Jeric

, Ziherl

, et al. Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease. J Cachexia Sarcopenia Muscle, 2011; 2(2):81–86.

28.

Barnes

, Celli

. Systemic manifestations and comorbidities of COPD. Eur Respir J, 2009; 33(5):1165–1185.

29.

Maurer

, Rebbapragada

, Borson

, Goldstein

, Kunik

, Yohannes

, et al. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest, 2008; 134(4 Suppl):43S–56S.

30.

Kunik

, Roundy

, Veazey

, Souchek

, Richardson

, Wray

, Stanley

. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest, 2005; 127(4):1205–1211.

31.

Lou

, Chen

, Zhang

, Yu

, Wang

, Chen

, et al. Effects of smoking, depression, and anxiety on mortality in COPD patients: a prospective study. Respir Care, 2014; 59(1):54–61.

32.

Steiner

, Barton

, Singh

, Morgan

. Nutritional enhancement of exercise performance in chronic obstructive pulmonary disease: a randomised controlled trial. Thorax, 2003; 58(9):745–751.

33.

Finnerty

, Keeping

, Bullough

, Jones

. The effectiveness of outpatient pulmonary rehabilitation in chronic lung disease: a randomized controlled trial. Chest, 2001; 119(6):1705–1710.

34.

Green

, Singh

, Williams

, Morgan

MDL

. A randomised controlled trial of four weeks versus seven weeks of pulmonary rehabilitation in chronic obstructive pulmonary disease. Thorax, 2001; 56(2):143–145.

35.

Behnke

, Taube

, Kirsten

, Lehnigk

, Jörres

, Magnussen

. Home-based exercise is capable of preserving hospital-based improvements in severe chronic obstructive pulmonary disease. Respir Med, 2000; 94(12):1184–1191.

36.

Greulich

, Koczulla

, Nell

, Kehr

, Vogelmeier

, Stojanovic

, et al. Effect of a three-week inpatient rehabilitation program on 544 consecutive patients with very severe COPD: a retrospective analysis. Respiration, 2015; 90(4):287–292.

37.

Stewart

, Drake

, Robertson

, Marwitz

, Kreutzer

, Cifu

. Benefits of an inpatient pulmonary rehabilitation program: a prospective analysis. Arch Phys Med Rehabil, 2001; 82(3):347–352.

38.

Clini

, Crisafulli

, Costi

, Rossi

, Lorenzi

, Fabbri

, Ambrosino

. Effects of early inpatient rehabilitation after acute exacerbation of COPD. Respir Med, 2009; 103(10):1526–1531.